Reveals distinct multi-omic profiles in study populations, indicating potential for precision medicine.
Motivation The increasing availability of multi-omic datasets from the same individuals presents the opportunity to uncover distinct molecular profiles across subgroups within a study population. These profiles may be linked to specific biological traits, such as disease status, and have distinct disease trajectories. Importantly, they could reveal robust, multi-layered molecular signatures with potential applications in early diagnosis, prognosis, and treatment advancing precision medicine. Although several integrative multi-omic methods have been developed in recent years, most are tailored to population-level analyses and are not well-suited for identifying signals specific to subpopulations. Results We developed MOBAA (Multi-Omic Bicluster Association Analysis), a novel data-driven integrative machine-learning framework for identifying subgroups within a study population that exhibit distinct multi-omic molecular profiles. MOBAA is scalable and capable of handling multiple omics simultaneously without relying on parametric distributional assumptions. It combines biclustering algorithms with hierarchical clustering-based module identification and uses permutation-derived empirical p-values. This approach provides a comprehensive and intuitive view of underlying biological variation and population heterogeneity facilitating discovery of complex, multi-layered molecular signatures. Availability and Implementation The code is available as MOBAA R package. All source code as well as comprehensive documentation and examples are provided at https://github.com/pmishra912/MOBAA.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: